Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-14 Sale | 2024-03-15 7:23 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 127,543 | $40.25 | $5,133,263 | 806,697 (Indirect) | View |
| 2024-03-11 Sale | 2024-03-13 7:53 pm | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner | 353,357 | $42.2 | $14,912,376 | 5,504,905 (Indirect Direct) | View |
| 2024-03-11 Sale | 2024-03-13 7:52 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 353,357 | $42.2 | $14,912,376 | 828,830 (Indirect) | View |
| 2024-03-04 Sale | 2024-03-04 6:21 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 3,344 | $41.86 | $139,967 | 241,990 (Direct) | View |
| 2024-03-04 Sale | 2024-03-04 6:12 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 3,934 | $41.86 | $164,664 | 329,851 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 4:34 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 400 | $45 | $18,000 | 137,192 (Direct) | View |
| 2024-02-20 Sale | 2024-02-21 6:46 pm | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $39.05 | $195,258 | 37,083 (Direct) | View |
| 2024-02-09 Sale | 2024-02-09 7:47 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 46,137 | $35.5 | $1,638,071 | 137,592 (Direct) | View |
| 2024-01-23 Sale | 2024-01-23 7:37 pm | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 10,000 | $30.05 | $300,470 | 21,349 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 5:15 pm | Kymera Therapeutics Inc. | KYMR | Chiniara Ellen Chief Legal Officer | 3,295 | $22.58 | $74,416 | 34,205 (Direct) | View |
| 2023-11-02 Purchase | 2023-11-06 6:07 pm | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes | 414,105 | $12.8 | $5,301,325 | 378,822 (Indirect Direct) | View |
| 2023-03-02 Sale | 2023-03-03 4:31 pm | Kymera Therapeutics Inc. | KYMR | Caughey Elaine Chief Business Officer | 714 | $31 | $22,132 | 82,324 (Direct) | View |
| 2023-03-02 Sale | 2023-03-03 4:30 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 1,298 | $31 | $40,233 | 187,209 (Direct) | View |
| 2023-03-02 Sale | 2023-03-03 4:30 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 1,370 | $31 | $42,465 | 247,068 (Direct) | View |
| 2023-01-11 Purchase | 2023-01-13 5:08 pm | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes | 41,007 | $30.51 | $1,251,191 | 2,218,295 (Indirect Direct) | View |
| 2023-01-11 Sale | 2023-01-13 4:53 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 126,474 | $30.22 | $3,821,739 | 890,148 (Indirect) | View |
| 2023-01-11 Sale | 2023-01-13 4:50 pm | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner | 126,474 | $30.22 | $3,821,739 | 5,858,262 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-28 Option Award | 2024-04-01 08:56 am | N/A 2034-03-27 | Kymera Therapeutics Inc. | KYMR | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 64,000 | $0 | 64,000 (Indirect) | View |
Ownership | 2024-04-01 08:53 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | BAKER BROS. ADVISORS LP Director | 0 | $0 | 13,946,423 (Indirect) | View |
| 2024-03-01 Option Award | 2024-03-04 6:21 pm | N/A 2034-02-28 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 170,625 | $0 | 241,990 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 6:16 pm | N/A 2034-02-28 | Kymera Therapeutics Inc. | KYMR | Chadwick Jeremy G Chief Operating Officer | 93,973 | $0 | 127,306 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 6:15 pm | N/A 2034-02-28 | Kymera Therapeutics Inc. | KYMR | Chiniara Ellen Chief Legal Officer | 152,286 | $0 | 186,491 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 6:12 pm | N/A 2034-02-28 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 530,000 | $0 | 530,000 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 6:12 pm | N/A 2034-02-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 218,750 | $0 | 329,851 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 4:34 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 400 | $2.08 | 137,192 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 4:34 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 400 | $0 | 137,192 (Direct) | View |
| 2024-02-20 Exercise | 2024-02-21 6:46 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $10.34 | 37,083 (Direct) | View |
| 2024-02-20 Exercise | 2024-02-21 6:46 pm | N/A 2030-07-28 | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $0 | 37,083 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-09 7:47 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 46,137 | $2.08 | 137,592 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-09 7:47 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 46,137 | $0 | 137,592 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-23 7:37 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 10,000 | $10.34 | 21,349 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-23 7:37 pm | N/A 2030-07-28 | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 10,000 | $0 | 21,349 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-02 5:43 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 9,000 | $2.08 | 1,135,542 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-02 5:43 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 9,000 | $0 | 1,135,542 (Direct) | View |
| 2023-11-03 Exercise | 2023-11-06 6:00 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 20,000 | $2.08 | 1,135,542 (Direct) | View |
| 2023-11-03 Exercise | 2023-11-06 6:00 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 20,000 | $0 | 1,135,542 (Direct) | View |
| 2023-08-08 Exercise | 2023-08-08 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 12,000 | $2.08 | 588,938 (Direct) | View |
| 2023-08-08 Exercise | 2023-08-08 4:30 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 12,000 | $0 | 588,938 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:55 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes | 12,000 | $0 | 4,724,983 (Indirect) | View |
| 2023-06-15 Option Award | 2023-06-20 4:16 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Sandor Victor Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Morgan Leigh Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | MARAGANORE JOHN Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Horobin Joanna Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Hrustanovic Gorjan Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-02 2:17 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $2.08 | 244,934 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-02 2:17 pm | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 10,000 | $0 | 244,934 (Direct) | View |
| 2023-05-22 Option Award | 2023-05-22 7:35 pm | N/A 2023-05-22 | Kymera Therapeutics Inc. | KYMR | Chadwick Jeremy G Chief Operating Officer | 233,333 | $0 | 233,333 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:31 pm | N/A 2033-02-28 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:31 pm | N/A 2033-02-28 | Kymera Therapeutics Inc. | KYMR | Caughey Elaine Chief Business Officer | 73,895 | $0 | 82,324 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:30 pm | N/A 2033-02-28 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 131,250 | $0 | 187,209 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:30 pm | N/A 2033-02-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 166,250 | $0 | 247,068 (Direct) | View |